Metraipolis › archive › dc_608760bf5d2c
Cognitive Processing Therapy or Relapse Prevention for comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A randomized clinical trial — Europe PMC PMID:36445895
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/36445895
- DOI
- 10.1371/journal.pone.0276111
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-10T05:14:52.029Z
- SHA-256 of the archived text
b46ad33a711fb52b1ea5026a611a0b6cfe9940530a986e315469329af6fb3a8c- Stable URL of this page
https://metraipolis.com/documento/dc_608760bf5d2c
How to cite
Cognitive Processing Therapy or Relapse Prevention for comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A randomized clinical trial — Europe PMC PMID:36445895 — Europe PMC (en), https://europepmc.org/article/MED/36445895 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_608760bf5d2c (Metraipolis archive dc_608760bf5d2c, sha256 b46ad33a711fb52b1ea5026a611a0b6cfe9940530a986e315469329af6fb3a8c)
BibTeX
@misc{dc608760bf5d2c,
title = {Cognitive Processing Therapy or Relapse Prevention for comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A randomized clinical trial — Europe PMC PMID:36445895},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/36445895},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_608760bf5d2c; sha256 b46ad33a711fb52b1ea5026a611a0b6cfe9940530a986e315469329af6fb3a8c},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36445895. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Objective: To compare a Posttraumatic Stress Disorder (PTSD) treatment (Cognitive Processing Therapy; CPT), an Alcohol Use Disorder (AUD) treatment (Relapse Prevention; RP), and assessment-only (AO) for those meeting diagnostic criteria for both PTSD and AUD. Method: Participants with current PTSD/AUD (N = 101; mean age = 42.10; 56% female) were initially randomized to CPT, RP, or AO and assessed post-treatment or 6-weeks post-randomization (AO). AO participants were then re-randomized to CPT or RP. Follow-ups were at immediate post-treatment, 3-, and 12-months. Mixed effects intent-to-treat models compared conditions on changes in PTSD symptom severity, drinking days, and heavy drinking days. Results: At post-treatment, participants assigned to CPT showed significantly greater improvement than those in AO on PTSD symptom severity (b = -9.72, 95% CI [-16.20, -3.23], d = 1.22); the RP and AO groups did not differ significantly on PTSD. Both active treatment conditions significantly decreased heavy drinking days relative to AO (CPT vs. AO: Count Ratio [CR] = 0.51, 95% CI [0.30, 0.88]; RP vs. AO: CR = 0.34, 95% CI [0.19, 0.59]). After re-randomization both treatment conditions showed substantial improvements in PTSD symptoms and drinking between pre-treatment and post-treatment over the 12-month follow-up period, with RP showing an advantage on heavy drinking days. Conclusion: Treatments targeting one or the other aspects of the PTSD/AUD comorbidity may have salutary effects on both PTSD and drinking outcomes. These preliminary results suggest that people with this comorbidity may have viable treatment options whether they present for mental health or addiction care. Trial registration: The trial is registered at clinicaltrials.gov (NCT01663337). Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-11-29). Identificativi: PMID 36445895 · PMCID PMC9707793 · DOI 10.1371/journal.pone.0276111. Descrittori MeSH principali: Alcoholism; Stress Disorders, Post-Traumatic; Cognitive Behavioral Therapy. Pagina: https://europepmc.org/article/MED/36445895 — https://doi.org/10.1371/journal.pone.0276111. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-10T04:34:39.457Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.